Skip to main content
. Author manuscript; available in PMC: 2018 Feb 2.
Published in final edited form as: Stata J. 2017 Oct;17(4):786–802.

Table 1.

Example 1. Comparison of summary measures estimated from publication and their corresponding reconstructed data

Original publication Guyot et al. (2012) ipdfc
Radiotherapy arm Percent [95% CI] Percent [95% CI]

Percent surviving one year 55 56.1 [49.6, 63.3] 56.9 [49.9, 63.2]
Percent surviving two years 41 41.1 [34.7, 48.6] 40.9 [34.2, 47.5]
Percent surviving three years 34 34.7 [28.4, 42.5] 33.5 [27.1, 40.1]
Median duration 14.9 14.9 [11.9, 23.0] 16.1 [11.9, 20.4]

Radiotherapy plus cetuximab arm Percent [95% CI] Percent [95% CI]

Survival rate at one year 63 64.0 [57.8, 70.9] 65.4 [58.2, 71.6]
Survival rate at two years 50 50.4 [43.9, 57.8] 51.0 [43.3, 58.6]
Survival rate at three years 47 46.7 [40.1, 54.4] 49.6 [40.4, 55.7]
Median duration 24.4 24.3 [15.7, 45.7] 23.7 [15.6, 46.8]

Hazard ratio with 95% CI

0.68 [0.52, 0.89] 0.73 [0.57, 0.94] 0.72 [0.56, 0.93]